← FDA Drug Approvals (Drugs@FDA)

NITROFURANTOIN

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: MANKIND PHARMA · Approved 2023-03-21

Drug application

FDA Application #

ANDA217272

Application type

Abbreviated New Drug Application (Generic)

Brand name

NITROFURANTOIN

Generic name

NITROFURANTOIN MACROCRYSTALS

Active ingredients

NITROFURANTOIN, MACROCRYSTALLINE

Dosage form

CAPSULE

Route

ORAL

Marketing status

Prescription

Sponsor

MANKIND PHARMA

Manufacturer

Lifestar Pharma LLC

First approval

2023-03-21

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown